|
Aspen Trading Update
|
|
23 August 2010
|
|
Shauneen Beukes
|
|
Trading Update regarding headline earnings per share for the 12 months ended 30 June 2010.
|
|
Read more »
|
|
Acquisition of Sigma Pharmaceuticals Limited by Aspen
|
|
16 August 2010
|
|
Shauneen Beukes
|
|
Announcement regarding the acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited ("Sigma") by Aspen
|
|
Read more »
|
|
Aspen Sigma SENS Cautionary Renewal
|
|
07 July 2010
|
|
|
|
Renewal of detailed cautionary announcement
|
|
Read more »
|
|
Aspen Sigma SENS Cautionary Notice
|
|
21 May 2010
|
|
Shauneen Beukes
|
|
Aspen shareholders are advised that Aspen has submitted an indicative non-binding proposal to acquire, either directly or through a wholly-owned subsidiary, Sigma Pharmaceuticals Limited at an enterprise value of A$1,492 million (approx. ZAR 9,796 million).
|
|
Read more »
|
|
Aspen and Strides restructure Oncology arrangements
|
|
18 March 2010
|
|
Shauneen Beukes
|
|
Aspen Pharmacare Holdings Limited (“Aspen”), listed on the JSE, South Africa (share code APN) and Strides Arcolab Limited, today announced a restructuring of their arrangements relating to the two oncology joint ventures (“JVs”) between Aspen and Strides, Onco Therapies Limited (“OTL”), India and Onco Laboratories Limited (“OLL”), Cyprus.
|
|
Read more »
|
|
Aspen raises profits by 31% as South African business shines
|
|
03 March 2010
|
|
|
|
Johannesburg - JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded strong returns for the six months ended 31 December 2009. The excellent performance from the South Africa business underpinned the results.
|
|
Read more »
|
|
Aspen Receives US $1 Million In Transfer of Technology Agreement
|
|
03 February 2010
|
|
|
|
Johannesburg - Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa’s leading pharmaceutical manufacturer, as part of the joint collaboration on expanding access to medicines to treat multidrug-resistant tuberculosis (MDR-TB).
|
|
Read more »
|
|
Aspen’s revenue increases by 80 percent as international business expands
|
|
08 September 2009
|
|
|
|
Johannesburg - JSE listed Aspen Pharmacare Holdings Limited, Africa’s largest pharmaceutical manufacturer, has produced excellent results for the year ended 30 June 2009. Prevailing global economic conditions did little to deter the strength of the Group’s performance, with the South African and Australian businesses continuing to perform well. Aspen’s international expansions resulted in substantially increased contributions from the offshore businesses, delivering an operating profit of R1.076
|
|
Read more »
|
|
Aspen’s S26 Assurance of Quality
|
|
07 September 2009
|
|
|
|
“At Aspen we understand that the wellbeing of your baby is of utmost importance. I confidently give you my assurance that Aspen’s S26 infant milk formula available to you in South Africa is of the highest quality. My confidence is based on these facts:
|
|
Read more »
|
|
Quality of S-26 in South Africa Guaranteed
|
|
30 August 2009
|
|
|
|
Johannesburg: Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for infant consumption.
|
|
Read more »
|